Dora M. Hammerl
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Tumor-associated macrophages: untapped molecular targets to improve T cell-based immunotherapy.
Journal: Molecular cancer
Published: July 16, 2025
CC chemokine receptor 2 is allosterically modulated by sodium ions and amiloride derivatives through a distinct sodium ion binding site.
Journal: Biochemical pharmacology
Published: March 06, 2024
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer.
Journal: Cancer discovery
Published: February 02, 2024
TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients.
Journal: Npj imaging
Published: September 21, 2023
Gene Engineering T Cells with T-Cell Receptor for Adoptive Therapy.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 27, 2022
Cancer germline antigens and tumor-agnostic CD8+ T cell evasion.
Journal: Trends in immunology
Published: February 21, 2022
Detection of Low-Frequency Epitope-Specific T Cells in Blood of Healthy Individuals according to an Optimized In Vitro Amplification System.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 07, 2021
Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer.
Journal: Nature communications
Published: June 02, 2020
Orthotopic editing of T-cell receptors.
Journal: Nature biomedical engineering
Published: December 08, 2019
Clonality, Antigen Recognition, and Suppression of CD8+ T Cells Differentially Affect Prognosis of Breast Cancer Subtypes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 23, 2019
Last Updated: 09/26/2026